New: NCI-funded clinical trial search
Mednet Logo

Do you start finerenone right away or wait for better glycemic control in a patient with CKD, type 1 diabetes, an HbA1c of 10% or higher, and persistent albuminuria on a maximally tolerated ACE inhibitor or ARB?

Community PollStarted

In a patient with CKD, type 1 diabetes, an HbA1c of 10% or higher, and persistent albuminuria on a maximally tolerated ACE inhibitor or ARB, when do you start finerenone?

59 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Nephrology · University of Toronto
Answered on

Good question – this has been looked at (Rossing et al., PMID 42160608), and benefits and safety are independent of A1c. Accordingly, it is reasonable to start finerenone at essentially any level of A1c, unless there is concern that the patient has an osmotic-induced state of volume depletion.

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Endocrinology · Brigham And Womens Hospital Endocrinology
Answered on

My clinical approach is usually to address one problem at a time in order to avoid patient confusion and competing priorities. Lowering A1C is clearly standard of care for patients with nephropathy and T1DM (Nathan et al., PMID 8366922). Adults with T1DM and an A1C over 10% either have problems acce...

Join for free or sign in to see the full answer

Mednet Member
Endocrinology · Washington University School of Medicine
Answered on

Finerenone is metabolically neutral, so it is possible to start it at any time in a person with T1D and albuminuria.

Join for free or sign in to see the full answer